Coronary heart-disease after treatment of hypertension
- PMID: 74494
- DOI: 10.1016/s0140-6736(78)90356-2
Coronary heart-disease after treatment of hypertension
Abstract
Within a group of 1026 men aged 47-54, cause-specific death-rates and the incidence of non-fatal myocardial infarction and stroke in treatment group of 635 hypertensive men (casual systolic B.P. greater than 175 or diastolic B.P. greater than 115 mm Hg on two occasions) treated at a hypertension clinic were compared with those in a control group of 391 men (causal systolic B.P. greater than 175 or diastolic greater than 115 mm Hg on only one occasion) who remained mainly untreated during their 4.3 years of follow-up. The predicted risk of coronary heart-disease (C.H.D.) at entry, calculated by a multiple logistic function, was slightly higher in the treatment group. Total death-rate during follow-up was significantly lower in the treatment group (3.3%) than in the control group (6.1%). The difference in death-rate for C.H.D. was of the same relative order (0.8% versus 1.5%), as was the incidence of non-fatal myocardial infarction (2.8% versus 5.4%), although none of the differences reached statistical significance. However, the pooled incidence of fatal and non-fatal C.H.D. was significantly lower in the treatment group (3.6%) than in the control group (6.9%). The results suggest that antihypertensive treatment might be effective in preventing or postponing C.H.D. in middle-aged men.
Similar articles
-
Effect of treatment of hypertension in the primary preventive trial, Göteborg, Sweden.Br J Clin Pharmacol. 1979;7 Suppl 2(Suppl 2):261S-265S. doi: 10.1111/j.1365-2125.1979.tb04699.x. Br J Clin Pharmacol. 1979. PMID: 37880 Free PMC article.
-
Antihypertensive drug treatment. Potential, expected, and observed effects on stroke and on coronary heart disease.Hypertension. 1989 May;13(5 Suppl):I45-50. doi: 10.1161/01.hyp.13.5_suppl.i45. Hypertension. 1989. PMID: 2490828 Review.
-
Stroke and coronary heart disease in treated hypertension -- a prospective cohort study over three decades.J Intern Med. 2005 Jun;257(6):496-502. doi: 10.1111/j.1365-2796.2005.01497.x. J Intern Med. 2005. PMID: 15910553
-
Mortality from stroke, coronary heart disease and all causes related to blood pressure and length of follow-up.Scand J Soc Med. 1994 Dec;22(4):273-82. doi: 10.1177/140349489402200406. Scand J Soc Med. 1994. PMID: 7716438
-
The Role of Beta-Blockers in the Treatment of Hypertension.Adv Exp Med Biol. 2017;956:149-166. doi: 10.1007/5584_2016_36. Adv Exp Med Biol. 2017. PMID: 27957711 Review.
Cited by
-
Beta-blockers and plasma triglycerides.Br Med J. 1978 May 20;1(6123):1348. doi: 10.1136/bmj.1.6123.1348. Br Med J. 1978. PMID: 25690 Free PMC article. No abstract available.
-
Hypothesis into theory--the development of aetiological concepts of ischaemic heart disease: a review.J R Soc Med. 1978 Nov;71(11):809-18. doi: 10.1177/014107687807101108. J R Soc Med. 1978. PMID: 215767 Free PMC article. Review. No abstract available.
-
Subjective symptoms and pharmacokinetics/dynamics of metoprolol CR in elderly subjects--a comparison with atenolol.Eur J Clin Pharmacol. 1990;38(6):571-8. doi: 10.1007/BF00278584. Eur J Clin Pharmacol. 1990. PMID: 2373131 Clinical Trial.
-
The effects of antihypertensive drugs on serum lipids and lipoproteins, I. Diuretics.Drugs. 1986 Sep;32(3):260-78. doi: 10.2165/00003495-198632030-00003. Drugs. 1986. PMID: 3530704 Review.
-
Relationship between hypertension and angina pectoris.Br J Clin Pharmacol. 1979;7 Suppl 2(Suppl 2):249S-253S. doi: 10.1111/j.1365-2125.1979.tb04697.x. Br J Clin Pharmacol. 1979. PMID: 157148 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources